Pharma and biotech outsourced clinical development
Pharmaceutical and biotechnology companies that outsource protocol design, patient and site management, monitoring, data management and regulatory-submission evidence across the cl
Intelligence / Healthtech & medtech market map / Clinical and regulatory support services / Clinical evidence and trial services
Clinical-trial design, patient and site management, monitoring, data management and evidence-generation services supporting regulatory submissions and payer coverage.
Split by customer type.
Pharmaceutical and biotechnology companies that outsource protocol design, patient and site management, monitoring, data management and regulatory-submission evidence across the cl
Medical-device and in-vitro-diagnostic vendors requiring pre-market trial design, patient and site management, monitoring, data management and submission-ready evidence for regulat
Digital-health vendors requiring clinical-validation studies, real-world evidence, patient or site operations where applicable, data management and evidence synthesis to support re
Medical-device and diagnostic vendors needing post-market observational studies, real-world evidence, patient and site management, data management and evidence updates to support p
$3.2B ($2.1B–$4.6B) · 2025 · Triangulated
CRO/clinical trial services are USD 57.5-59.6B in 2025 growing to about USD 106B by 2033-2035 at 6.5-7.5% [1]. Medtech and diagnostics vendors are a minority of CRO spend (most is pharma); a 5-8% share is assumed for medtech/diagnostics/digital-health buyers, giving USD 2.9-4.8B, and a USD 3.2B midpoint for 2025. Forecast scaled at the 6.5-7.5% market growth rate [1].
// Sell into Clinical evidence and trial services